Vela Diagnostics has received the European CE mark for in vitro diagnostic use of the ViroKey™ SARS-CoV-2 RT-PCR Test v2.0, a Covid-19 detection test. The test also received Provisional Authorisation from the Singapore’s Health Sciences Authority. It is a probe-based reverse transcription polymerase chain reaction (PCR) test that specifically targets the ORF1a and N genes of the SARS-CoV-2 genome to detect infection.
National Tsing Hua University Institute of Biomedical Engineering’s Professor Cheng Chao-Min has developed a new Covid-19 test that enables a physician to offer treatment on time to high-risk patients. The test was developed in partnership with the Tri-Service General Hospital and the prototype is undergoing the clinical validations at different medical centres.
Go deeper with GlobalData
Helix has partnered with San Diego County to increase the availability of Covid-19 testing across the county for those who require it the most. Under the public-private partnership, San Diego County will be provided with around 2,000 Helix Covid-19 Test, a RT-PCR test, daily.
electroCore has received Emergency Use Authorisation (EUA) from the US Food and Drug Administration (FDA) for the use of gammaCore Sapphire CV non-invasive vagus nerve stimulation (nVNS) to treat adult patients who are confirmed or suspected to have Covid-19. The nVNS will be used for patients who are suffering from asthma-related dyspnea and reduced airflow and drug therapies do not offer symptom relief.
